Oncternal Therapeutics, Inc. (ONCT)
0.5266
0.00 (0.00%)
USD |
NASDAQ |
Sep 08, 16:00
Oncternal Therapeutics Debt to Equity Ratio
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| September 30, 2024 | 0.0209 |
| June 30, 2024 | 0.0149 |
| March 31, 2024 | 0.0121 |
| December 31, 2023 | 0.0106 |
| September 30, 2023 | 0.0092 |
| June 30, 2023 | 0.0081 |
| March 31, 2023 | 0.001 |
| December 31, 2022 | 0.0014 |
| September 30, 2022 | 0.0018 |
| June 30, 2022 | 0.0021 |
| March 31, 2022 | 0.0004 |
| December 31, 2021 | 0.0009 |
| September 30, 2021 | 0.0013 |
| June 30, 2021 | 0.0016 |
| March 31, 2021 | 0.0019 |
| December 31, 2020 | 0.0004 |
| September 30, 2020 | 0.0242 |
| June 30, 2020 | 0.0436 |
| March 31, 2020 | 0.0148 |
| December 31, 2019 | 0.0133 |
| September 30, 2019 | 0.0124 |
| June 30, 2019 | 0.0116 |
| March 31, 2019 | 0.002 |
| December 31, 2018 | -1.572 |
| September 30, 2018 | 0.00 |
| Date | Value |
|---|---|
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
| December 31, 2013 | 0.00 |
| September 30, 2013 | 0.00 |
| June 30, 2013 | 0.00 |
| March 31, 2013 | 0.00 |
| December 31, 2012 | 0.0001 |
| September 30, 2012 | 0.00 |
| June 30, 2012 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| AbbVie, Inc. | -11.93 |
| Abeona Therapeutics, Inc. | 0.1552 |
| America Great Health | -0.6512 |
| Acumen Pharmaceuticals, Inc. | 0.5526 |
| Aardvark Therapeutics, Inc. | 0.0091 |